Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Cancer, EQUIP Trial

Conditions: Castration-Sensitive Prostate Adenocarcinoma; Metastatic Castration-Sensitive Prostate Adenocarcinoma; Stage IVB Prostate Cancer AJCC v8
Interventions: Drug: Androgen Receptor Pathway Inhibitor; Drug: Transdermal Estrogen; Procedure: Bone Scan; Procedure: Computed Tomography; Procedure: Dual X-ray Absorptiometry; Biological: Gonadotropin-releasing Hormone Analog; Procedure: Magnetic Resonance Imaging; Other: Survey Administration; Procedure: Biospecimen Collection
Sponsors: University of Washington; Institute for Prostate Cancer Research (IPCR)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

March 13, 2026Comments OffCardiology | Cardiology Clinical Trials | Cardiology Studies | ClinicalTrials.gov | Drug Trials Near Me | US National Library of Medicine
Comments